FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF CHRONOTHERAPEUTIC DRUG DELIVERY OF ROSUVASTATIN BY COMPRESSED COATED TECHNIQUE

Journal Title: Int J of Pharm Rev& Res - Year 2015, Vol 5, Issue 3

Abstract

Rosuvastatin is an HMG –COA reductase inhibitor, primarily used for the treatment of hyper cholestremia associated with cardiovascular diseases. It belongs to BCS class II having a half-life of 19 hrs and 20% bioavailability. The purpose of the present work was to develop a press-coated, chronotherapeutic drug delivery system. The core tablet was formulated using the super-disintegrants and croscarmellose sodium. A press-coated tablet contained the polymers ethyl cellulose, eudragit L 100 &S 100. The tablets were evaluated for physical characteristics are pre and post compression parameters, lag time, FTIR, DSC, and in vitro the 10% superdisintgrant showed good results. The FTIR and DSC study predicted no chemical interactions between the drug and excipients. The lag time for the tablet coated with 100 mg ethyl cellulose was 9±0.1 hrs with90±1.5% drug release; with 100 mg eudragit L100, the lag time was 6±0.1 hrs with 89.71±1.2% drug release; and with 100 mg eudragit S100, the lag time was6±0.2 hrs with 88±1.7% drug release. The release mechanism of the tablet followed the Korsmeyer-Peppas equation and a first-order release pattern& lag time behavior have shown good in vitro release

Authors and Affiliations

Gatla Narasimha Reddy1 , B. Arunkumar2 , Ramavath Naresh Naik2

Keywords

Related Articles

DIRECT RESTORATIONS OF ANTERIOR TEETH: A REVIEW

The demand of direct restorations is increasing nowadays. Direct composite resin bonding procedures are growing in popularity as conservative and predictable restorative treatment alternatives. It not only has a good suc...

DEVELOPMENT AND INVITRO CHARACTERIZATION OF PACLITAXEL SUSTAINED RELEASE MICROSPHERS

The objective of the present work was to formulate and evaluate sustained release paclitaxel microspheres for treating breast, ovarian and colon cancer effectively. Sustained release paclitaxel microspheres for minimum f...

DRUG TARGETING: BASIC CONCEPTS AND NANOSYSTEMS IN DRUG TARGETING

At present about 95% of all new potential therapeutic have poor pharmacokinetic and pharmacodynamics property. Either they get destroyed before going to systemic circulation or they get poorly absorbed. Hence, there is n...

NATURAL PRODUCTS BOTACHEMICAL POTENTIALITY AND HEALTH PERSPECTIVES

It‟s well established that oxygen is essential for survival and energy generation in all-living organisms and ~5% of its inhaled part is converted into free radicals (either ROS or RNS) as a by-product of aerobic metabol...

CURCUMIN – A SALUBRIOUS ASSET TO IMMUNE SYSTEM

Ayurveda is the holistic and philosophical system of medicine which has been developed over thousands of years with usage of different types of herbs to cure diseases and ailments. India is the home of Ayurveda promotes...

Download PDF file
  • EP ID EP138299
  • DOI -
  • Views 117
  • Downloads 0

How To Cite

Gatla Narasimha Reddy1, B. Arunkumar2, Ramavath Naresh Naik2 (2015). FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF CHRONOTHERAPEUTIC DRUG DELIVERY OF ROSUVASTATIN BY COMPRESSED COATED TECHNIQUE. Int J of Pharm Rev& Res, 5(3), 299-304. https://europub.co.uk/articles/-A-138299